http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1350582-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c82fea9cd3dc48540ebd26d3b952479
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-56
filingDate 1970-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1974-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1350582-A
titleOfInvention Cerivatives of 2-pyrrolidinone
abstract 1350582 Substituted phenyl-2-pyrrolidinones UCB SA 21 July 1971 [24 July 1970] 35948/70 Heading C2C Novel substituted phenyl-2-pyrrolidinones of the general formula wherein R is a halogen atom, an alkyl, haloalkyl, alkenyl, alkynyl or alkoxy radical having up to 5 carbon atoms, or a nitro, amino or hydroxyl group; R 1 is an alkyl, alkenyl or alkynyl radical having up to 5 carbon atoms or an optionally ring-substituted aryl or aralkyl radical, R 2 is a hydrogen atom or a C 1-5 alkyl or aryl radical, R 3 is a hydrogen atom, an alkyl, alkenyl or alkynyl radical having up to 7 carbon atoms, or a cycloalkyl or aralkyl radical and n is 1, 2 or 3, and the cis- and trans-stereoisomers, racemates and optically-active isomers thereof are prepared (a) by cyclizing a 4-aminobutyric acid or an alkyl ester thereof of the general formula H(R 3 )N-A-COOX, wherein X is a hydrogen atom or a C 1-4 alkyl group and A is a trimethylene chain substituted by (R) n -phenyl, R 1 and R 2 radicals; (b) by hydrolysing a 2- iminopyrrolidine of the general formula (c) by reacting, at elevated temperature, a lactone of the general formula with a compound of the general formula R 3 NH 2 ; (d) by cyclizing, in the presence of an alkaline condensation agent, a halobutyramide of the general formula Hal-S-CONH(R 3 ), wherein Hal is a halogen atom; (e) by thermally decarboxylating a 2-pyrrolidinone-3-carboxylic acid of the general formula (f) when R 3 is other than a hydrogen atom, by reacting the corresponding compound in which R 3 is a hydrogen atom with a compound of the general formula R 3 -Hal in the presence of an alkaline condensation agent; (g) when R is a nitro group in the para-position, by nitrating the corresponding compound in which R is a hydrogen atom; (h) when R is an amino group in the para-position, by reducing the corresponding compound in which R is a nitrogroup in the para-position; (i) when R is a halogen atom in the para-position, by diazotizing the corresponding compound in which R is an amino group in the para-position in an aqueous medium with an alkali metal nitrite in the presence of a hydrohalic acid at 0-5‹ C. and subjecting the resulting diazonium salt to a Sandmeyer reaction in the presence of Cu powder or a cuprous halide; and (j) when R is a hydroxyl group in the paraposition, by diazotizing the corresponding compound in which R is an amino group in the paraposition in an aqueous medium with an alkali metal nitrite in the presence of a hydrohalic acid at 0-5‹ C. and heating the aqueous solution of the resulting diazonium salt; followed optionally by separating resulting diastereo isomer mixtures into the cis- and trans-components thereof or separating resulting racemates into the optically-active isomers thereof. 4-Aminobutyric acids and alkyl esters thereof of the second general formula above are prepared by catalytically hydrogenating the corresponding 3-cyanopropionic acid or alkyl ester thereof (prepared by reaction of the corresponding acetonitrile and bromoacetic acid or alkyl ester thereof in the presence of sodium hydride). Ethyl 3 - p - chlorophenyl - 4 - nitropentanoate is prepared by reaction of nitroethane, ethyl pchloro-cinnamate and a 35% solution of trimethylbenzyl - ammonium hydroxide in methanol. Pharmaceutical compositions having effects on the central nervous system comprise, as active ingredient, a substituted phenyl-2-pyrrolidinone of the first general formula above, in admixture with a solid or liquid pharmaceutical diluent or carrier.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4956473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03067986-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9219594-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6022870-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4958044-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5977149-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5131947-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2954236-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5747516-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2923553-A1
priorityDate 1970-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422009391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420965918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22391770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452451264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451105532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410068132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411225555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411043156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12778904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54409241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414013700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448056355

Total number of triples: 60.